![](/img/cover-not-exists.png)
184TiPFIND: A phase II study to evaluate the efficacy of erdafitinib in FGFR-altered squamous NSCLC
Nogova, L, Malchers, F, Hillmer, A, Merkelbach-Bruse, S, Pinto, A, Woempner, C, Riedel, R, Scheffler, M, Michels, S, Porre, P De, Santiago-Walker, A, Fischer, R N, Abdulla, D S, Thomas, R, Buettner, RVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz063.082
Date:
April, 2019
File:
PDF, 79 KB
2019